Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does INCOBOTULINUMTOXINA Cause Therapy partial responder? 28 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 28 reports of Therapy partial responder have been filed in association with INCOBOTULINUMTOXINA. This represents 0.6% of all adverse event reports for INCOBOTULINUMTOXINA.

28
Reports of Therapy partial responder with INCOBOTULINUMTOXINA
0.6%
of all INCOBOTULINUMTOXINA reports
0
Deaths
0
Hospitalizations

How Dangerous Is Therapy partial responder From INCOBOTULINUMTOXINA?

Of the 28 reports.

Is Therapy partial responder Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for INCOBOTULINUMTOXINA. However, 28 reports have been filed with the FAERS database.

What Other Side Effects Does INCOBOTULINUMTOXINA Cause?

Drug ineffective (1,621) Off label use (1,127) Therapeutic response decreased (598) Injection site pain (300) Product preparation issue (174) Headache (164) Injection site swelling (164) Overdose (152) Pain (145) Eyelid ptosis (122)

What Other Drugs Cause Therapy partial responder?

CYCLOPHOSPHAMIDE (1,397) RITUXIMAB (1,219) DEXAMETHASONE (1,199) PREDNISONE (1,176) PEMBROLIZUMAB (1,125) CARBOPLATIN (1,096) DOXORUBICIN (834) METHOTREXATE (775) VINCRISTINE (707) ETOPOSIDE (670)

Which INCOBOTULINUMTOXINA Alternatives Have Lower Therapy partial responder Risk?

INCOBOTULINUMTOXINA vs INDACATEROL INCOBOTULINUMTOXINA vs INDAPAMIDE INCOBOTULINUMTOXINA vs INDAPAMIDE\PERINDOPRIL INCOBOTULINUMTOXINA vs INDAPAMIDE\PERINDOPRIL ARGININE INCOBOTULINUMTOXINA vs INDAPAMIDE\PERINDOPRIL ERBUMINE

Related Pages

INCOBOTULINUMTOXINA Full Profile All Therapy partial responder Reports All Drugs Causing Therapy partial responder INCOBOTULINUMTOXINA Demographics